Publication | Open Access

Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and α-adrenolytic activity

Molecular PharmacologyDerivative (Chemistry)BiochemistryMedicinePharmacological AgentPharmacotherapyDrug DevelopmentPharmacological EvaluationPharmacologyPharmaceutical Chemistryα-Adrenolytic ActivityDrug Discovery